1-5 of 5
Abraham Fong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL

Clinical Trials & Observations
Jonathan W. Friedberg, Andres Forero-Torres, Rodolfo E. Bordoni, Vivian J. M. Cline, Dipti Patel Donnelly, Patrick J. Flynn, Gregg Olsen, Robert Chen, Abraham Fong, Yinghui Wang, Christopher A. Yasenchak
Journal: Blood
Blood (2017) 130 (26): 2829–2837.
https://doi.org/10.1182/blood-2017-06-787200
Published: 2017
Includes: Supplemental data
Journal Articles

Preliminary Results from a Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma

Alex F Herrera, MD, Nancy L Bartlett, MD, Radhakrishnan Ramchandren, MD, Julie M Vose, MD, Alison J Moskowitz, MD, Tatyana A Feldman, MD, Ann S LaCasce, MD, Stephen M Ansell, MD PhD, Craig H. Moskowitz, MD, Keenan Fenton, Kazunobu Kato, MD, Abraham Fong, MD PhD, Ranjana H Advani, MD
Journal: Blood
Blood (2016) 128 (22): 1105.
https://doi.org/10.1182/blood.V128.22.1105.1105
Published: 2016
Journal Articles

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations Brief Report
Robert Chen, Ajay K. Gopal, Scott E. Smith, Stephen M. Ansell, Joseph D. Rosenblatt, Kerry J. Savage, Joseph M. Connors, Andreas Engert, Emily K. Larsen, Dirk Huebner, Abraham Fong, Anas Younes
Journal: Blood
Blood (2016) 128 (12): 1562–1566.
https://doi.org/10.1182/blood-2016-02-699850
Published: 2016
Includes: Supplemental data
Journal Articles

Five-Year Survival Data Demonstrating Durable Responses from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma

Robert Chen, Ajay K. Gopal, MD, Scott E. Smith, Stephen Ansell, MD PhD, Joseph D. Rosenblatt, Kerry J. Savage, MDMSc, Joseph M. Connors, MD, Andreas Engert, Emily K Larsen, Dirk Huebner, Abraham Fong, Anas Younes, MD
Journal: Blood
Blood (2015) 126 (23): 2736.
https://doi.org/10.1182/blood.V126.23.2736.2736
Published: 2015
Journal Articles

Brentuximab Vedotin in Combination with Dacarbazine or Bendamustine for Frontline Treatment of Hodgkin Lymphoma in Patients Aged 60 Years and Above: Interim Results of a Multi-Cohort Phase 2 Study

Christopher A. Yasenchak, MD, Andres Forero-Torres, Vivian Jean Mikao Cline-Burkhardt, Rodolfo E Bordoni, MD, Dipti Patel-Donnelly, MD, Patrick J. Flynn, MD, Robert Chen, Abraham Fong, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2015) 126 (23): 587.
https://doi.org/10.1182/blood.V126.23.587.587
Published: 2015